It’s official: Novavax seeks FDA’s green light for Covid vaccine candidate

The company's long-awaited application for its U.S. launch follows several months of manufacturing delays and buildup, as well as a flurry of similar submissions in other countries.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.